Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Blood
; 137(4): 513-523, 2021 01 28.
Article
in En
| MEDLINE
| ID: mdl-33507295
Full text:
1
Database:
MEDLINE
Main subject:
Triazoles
/
Lymphoma, Non-Hodgkin
/
Antineoplastic Combined Chemotherapy Protocols
/
Salicylates
/
Choline
/
Receptors, Cytoplasmic and Nuclear
/
Karyopherins
/
DNA Repair
/
S Phase Cell Cycle Checkpoints
/
Hydrazines
Type of study:
Clinical_trials
Language:
En
Year:
2021
Type:
Article